GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

> Following FDA approval of rATIII, the metric for deals will once again shift<
Agreed. I related on Y!, that I once speculated in Kroger,
they were deemed trash and shortly wallpaper, but I saw that
operating cash flow was more than enough to dig them out of
the hole they were in, and as it did their perceived prospects
would move my way. I think this a parallel case: the least
bit of good news here alters the gauge function to radically
advance the bull case.